Regulations.gov document
Fresenius Kabi USA, LLC, et al.; Withdrawal of Approval of Six Abbreviated New Drug…
Notice · FDA-2023-N-0722 · posted Mar 16, 2023
Key facts
| Document ID | FDA-2023-N-0722-0001 |
|---|---|
| Title | Fresenius Kabi USA, LLC, et al.; Withdrawal of Approval of Six Abbreviated New Drug Applications |
| Document type | Notice |
| Subtype | Withdrawal |
| Agency | FDA |
| Docket | FDA-2023-N-0722 |
| Posted | Mar 16, 2023 |
| Federal Register citation | 88 FR 16271 |
| FR document number | 2023-05360 |
| Comment period opens | Mar 16, 2023 |
| Effective date | Mar 16, 2023 |
At a glance
- 1–9 Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: